SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-218601
Filing Date
2012-05-08
Accepted
2012-05-08 16:32:57
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d334987d10q.htm 10-Q 593262
2 SECTION 302 CEO CERTIFICATION d334987dex311.htm EX-31.1 10349
3 SECTION 302 CFO CERTIFICATION d334987dex312.htm EX-31.2 10600
4 SECTION 906 CEO CERTIFICATION d334987dex321.htm EX-32.1 3949
5 SECTION 906 CFO CERTIFICATION d334987dex322.htm EX-32.2 4124
  Complete submission text file 0001193125-12-218601.txt   4424357

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT slxp-20120331.xml EX-101.INS 575104
7 XBRL TAXONOMY EXTENSION SCHEMA slxp-20120331.xsd EX-101.SCH 44212
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE slxp-20120331_cal.xml EX-101.CAL 43027
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE slxp-20120331_def.xml EX-101.DEF 127497
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE slxp-20120331_lab.xml EX-101.LAB 350861
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE slxp-20120331_pre.xml EX-101.PRE 260306
Mailing Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615
Business Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23265 | Film No.: 12821837
SIC: 2834 Pharmaceutical Preparations